Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) have been given a consensus recommendation of “Hold” by the twenty-one brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have assigned a buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $15.13.

MDRX has been the subject of a number of research analyst reports. KeyCorp reissued a “hold” rating on shares of Allscripts Healthcare Solutions in a research report on Friday, October 27th. Zacks Investment Research cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. Robert W. Baird upped their target price on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday, November 3rd. Cowen raised Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and upped their target price for the company from $13.00 to $16.00 in a research report on Monday, September 11th. Finally, SunTrust Banks reissued a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, November 3rd.

Shares of Allscripts Healthcare Solutions (NASDAQ MDRX) traded down $0.13 during midday trading on Friday, hitting $14.27. The company had a trading volume of 4,901,666 shares, compared to its average volume of 2,343,689. The firm has a market cap of $2,600.00, a PE ratio of 33.49, a PEG ratio of 2.56 and a beta of 1.34. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.20. Allscripts Healthcare Solutions has a 1 year low of $10.19 and a 1 year high of $14.51.

In other Allscripts Healthcare Solutions news, SVP James Hewitt sold 36,796 shares of the stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the sale, the senior vice president now directly owns 181,766 shares of the company’s stock, valued at approximately $2,564,718.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Richard J. Poulton sold 15,000 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $13.56, for a total value of $203,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 71,796 shares of company stock valued at $992,992 over the last ninety days. 0.91% of the stock is owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Archford Capital Strategies LLC lifted its holdings in shares of Allscripts Healthcare Solutions by 6,124.0% in the 2nd quarter. Archford Capital Strategies LLC now owns 6,224 shares of the software maker’s stock valued at $958,000 after buying an additional 6,124 shares during the period. Bank of Montreal Can lifted its holdings in shares of Allscripts Healthcare Solutions by 6.9% in the 2nd quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock valued at $135,000 after buying an additional 689 shares during the period. World Asset Management Inc lifted its holdings in shares of Allscripts Healthcare Solutions by 0.7% in the 2nd quarter. World Asset Management Inc now owns 11,419 shares of the software maker’s stock valued at $146,000 after buying an additional 81 shares during the period. ETF Managers Group LLC acquired a new stake in shares of Allscripts Healthcare Solutions in the 2nd quarter valued at approximately $152,000. Finally, Sheaff Brock Investment Advisors LLC acquired a new stake in shares of Allscripts Healthcare Solutions in the 3rd quarter valued at approximately $174,000.

WARNING: This article was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/11/allscripts-healthcare-solutions-inc-mdrx-receives-15-13-average-target-price-from-analysts.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related stocks with our FREE daily email newsletter.